Vinblastine for Leukoreduction in Newly Diagnosed AML and Hyperleukocytosis

NCT05062278 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

46

Enrollment

OTHER

Sponsor class

Conditions

AML
Hyperleukocytosis

Interventions

DRUG: Vinblastine
DRUG: Hydroxyurea capsules

Sponsor

Hospital Universitario Dr. Jose E. Gonzalez